Description
This training series is a presentation of the stimulant epidemic, current treatment practices and an in-depth training on the TRUST protocol to allow programs to successfully implement a stimulant use disorder intervention. Information covered will include: Current epidemiological data on the stimulant epidemic, an overview of the evidence-based treatments, including contingency management, exercise, cognitive behavioral therapy, community reinforcement approach, and motivational interviewing. This is an interactive training intended to provide program staff with ample opportunity to acquire, practice and refine their skills.
The TRUST Therapist Manual and Patient Workbook will be provided electronically.
The TRUST Therapist Manual and Patient Workbook will be provided electronically.
Learning Objectives
1. Participants will obtain knowledge regarding the latest evidence based practice strategies for Stimulant use disorder treatment.
2. Participants will learn about the health effects of stimulant use and how to apply in placement criteria and treatment planning.
3. Participants will learn how to adapt and apply Treatment for individuals who use stimulants while on MOUD
2. Participants will learn about the health effects of stimulant use and how to apply in placement criteria and treatment planning.
3. Participants will learn how to adapt and apply Treatment for individuals who use stimulants while on MOUD
Five-Part Training
This is a five-part training series. The introduction lecture and four training sessions need to be attended in order to have complete attendance.
All sessions will be hosted virtually on zoom.
All sessions will be hosted virtually on zoom.
|
Session 1
Wednesday, January 8 1:00-3:00pm Stimulants 2025: Epidemiology, Effects and Clinical Challenges |
Session 2
Wednesday, January 15 1:00-3:00pm -Chapter 1: Stimulant Use Disorder & Treatment Approaches -Chapter 2: Therapist Orientation -Chapter 3: Motivational Interviewing -Chapter 4: Patient Orientation Session |
Session 3
Wednesday, January 22 1:00-3:00pm -Chapter 5: Incentive Program -Chapter 6: Exercise for Stimulant Use Disorder |
Session 4
Wednesday, January 29 1:00-3:00pm -Chapter 7: Drug Cessation Group -Chapter 8: Recovery Skill Group |
Session 5
Wednesday, February 5 1:00-3:00pm -Chapter 9: Individual Coaching Sessions -Recovery Skills -Continuing Care Plan -Trust Implementation Schedule -Incentive Plan Implementation -Promoting Exercise |
Stimulant Treatment Implementation (Coaching) Calls
During January there was a series of 5 calls that covered materials on the treatment of people with stimulant use disorders. This included information on a set of evidence-based treatments, including contingency management, cognitive behavioral therapy, community reinforcement approach and physical exercise.
These were presented in a package we call TRUST (Treatment for Individuals who Use Stimulants).
The implementation/coaching calls beginning on Feb 12 at 1 pm CT. We invite those who attended the previous TRUST Training Series to attend. It would be very helpful if you could tell us of your intention to attend and if you plan to use the sessions to: 1 Implement TRUST; 2. Discuss contingency management; 3 Another reason.
These were presented in a package we call TRUST (Treatment for Individuals who Use Stimulants).
The implementation/coaching calls beginning on Feb 12 at 1 pm CT. We invite those who attended the previous TRUST Training Series to attend. It would be very helpful if you could tell us of your intention to attend and if you plan to use the sessions to: 1 Implement TRUST; 2. Discuss contingency management; 3 Another reason.
Every Other Wednesday
1pm to 2pm CT
February 12
February 26
March 12
March 26
April 9
April 23
1pm to 2pm CT
February 12
February 26
March 12
March 26
April 9
April 23
The respective zoom links for these calls are located on the calendar invite for each day.
Resources
|
Base Resources
|
| ||||||||
|
Slide Decks for Session 1 (Stimulants 2025: Epidemiology, Effects and Clinical Challenges)
used on Wednesday, January 8 |
| ||||
|
Slide Decks for Session 2
used on Wednesday, January 15 |
| ||||
|
Slide Decks for Session 3
used on Wednesday, January 22 |
| ||||||
|
Slide Decks for Session 5
Used on Wednesday, February 5 |
| ||
Trainers
Richard A. Rawson, Ph.D., is Professor Emeritus at the UCLA Department of Psychiatry and a Research Professor at the Vermont Center for Behavior and Health at the University of Vermont. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. Dr. Rawson conducted numerous clinical trials on pharmacological and psychosocial/behavioral addiction treatments for the treatment of individuals with cocaine and methamphetamine disorders. He has represented the US at numerous international meetings on methamphetamine. He has led addiction research and training projects for the United Nations, the World Health Organization, and the U.S. State Department, exporting science-based knowledge to many parts of the world. He is a member of the Motivational Incentives Policy Group, a volunteer group that is working to reduce obstacles to the use of contingency management for treatment of stimulant use disorder. He is currently providing technical assistance to 8 states on the development of treatment services for individuals with stimulant use disorder. Dr. Rawson has published 3 books, 40 book chapters, and over 250 peer-reviewed articles and has conducted many workshops, paper presentations, and training sessions.
Albert L. Hasson, MSW, ADDICTION RESEARCHER AND TREATMENT PROVIDER, UCLA, LOS ANGELES, CA
Albert L. Hasson received his MSW from the University of California – Los Angeles (UCLA) and has worked in the field of addiction medicine as a researcher, treatment provider, and trainer since 1977. He began his career working as a research associate at the Sepulveda Veterans Administration Medical Center evaluating naltrexone for the treatment of opioid use disorders. Mr. Hasson participated in the development of the evidence-based Matrix Model, a cognitive behavioral intervention for the treatment of stimulant disorders, and established the Matrix Institute on Addictions, Los Angeles, an opioid treatment program serving individuals with co-occurring mental and physical health and substance use disorders. During his role as the Node Coordinator of the Pacific Region Node of the National Institute on Drug Abuse, Clinical Trials Network, Mr. Hasson provided oversight for the development and conduct of large, multi-site clinical trials evaluating medications and behavioral therapies for substance use disorders. As a project director and trainer for the Pacific Southwest Addiction Technology Transfer Center at the UCLA Integrated Substance Abuse Programs, Mr. Hasson trained mental health, corrections, and substance use disorder providers on evidence-based interventions, including Motivational Interviewing, Cognitive Behavioral Therapy, Contingency Management, medications for opioid use disorder, and the American Society of Addiction Medicine Criteria. Mr. Hasson recently retired from the UCLA Integrated Substance Abuse Programs and is currently working as a private consultant to a number of State agencies around the country.
Albert L. Hasson, MSW, ADDICTION RESEARCHER AND TREATMENT PROVIDER, UCLA, LOS ANGELES, CA
Albert L. Hasson received his MSW from the University of California – Los Angeles (UCLA) and has worked in the field of addiction medicine as a researcher, treatment provider, and trainer since 1977. He began his career working as a research associate at the Sepulveda Veterans Administration Medical Center evaluating naltrexone for the treatment of opioid use disorders. Mr. Hasson participated in the development of the evidence-based Matrix Model, a cognitive behavioral intervention for the treatment of stimulant disorders, and established the Matrix Institute on Addictions, Los Angeles, an opioid treatment program serving individuals with co-occurring mental and physical health and substance use disorders. During his role as the Node Coordinator of the Pacific Region Node of the National Institute on Drug Abuse, Clinical Trials Network, Mr. Hasson provided oversight for the development and conduct of large, multi-site clinical trials evaluating medications and behavioral therapies for substance use disorders. As a project director and trainer for the Pacific Southwest Addiction Technology Transfer Center at the UCLA Integrated Substance Abuse Programs, Mr. Hasson trained mental health, corrections, and substance use disorder providers on evidence-based interventions, including Motivational Interviewing, Cognitive Behavioral Therapy, Contingency Management, medications for opioid use disorder, and the American Society of Addiction Medicine Criteria. Mr. Hasson recently retired from the UCLA Integrated Substance Abuse Programs and is currently working as a private consultant to a number of State agencies around the country.
